. Recently (Fig. 1A) (Fig. 1F) . Further, we determined whether the activation of p53 and p21 was attributed to the increase in protein stability. Cells were either treated or untreated with NaHS. Six hours after NaHS treatment, cells were treated with cycloheximide (CHX, 10 g/ml) to inhibit the de novo protein synthesis. p53 and p21 steady state levels were monitored at various time-points after CHX addition (Fig. 1C) . The rate at which p53 and p21 levels decreased under these conditions was measured as protein stability. In the untreated cells, p53 and p21 levels were decreased following CHX treatment. In contrast to H2S-treated cells, p53 level is elevated for up to 6 hrs following CHX treatment. However, CHX treatment blocks the p21 expression. In the present study, we investigated the subcellular expression of p53 followed by the H2S treatment. Cells treated earlier with NaHS and followed by CHX treatment were treated earlier with NaHS for 6 hrs were sampled at the indicated time-points and subjected to cytoplasmic (Fig. 1D) and nuclear (Fig. 1E) fractions as explained earlier [10, 11] 
In recent years, it has become clear that hydrogen sulphide (H2S) plays a number of biological roles and may function as a novel gasotransmitter in the body alongside nitric oxide (NO) and carbon monoxide (CO) [1]. H2S is synthesized naturally from L-cysteine in mammalian tissues in a reaction catalysed by two enzymes, cystathionine-␥-lyase (CSE) and cystathionine-␤-synthetase (CBS)
. Recently, attention has been focused on the potential physiological and pathophysiological role of H2S in the body. It has been shown, for example, H2S plays a role in the regulation of vascular function both in health and disease [3] [4] [5] (Fig. 1C) . The rate at which p53 and p21 levels decreased under these conditions was measured as protein stability. In the untreated cells, p53 and p21 levels were decreased following CHX treatment. In contrast to H2S-treated cells, p53 level is elevated for up to 6 hrs following CHX treatment. However, CHX treatment blocks the p21 expression. In the present study, we investigated the subcellular expression of p53 followed by the H2S treatment. Cells treated earlier with NaHS and followed by CHX treatment were treated earlier with NaHS for 6 hrs were sampled at the indicated time-points and subjected to cytoplasmic (Fig. 1D) and nuclear (Fig. 1E) fractions as explained earlier [10, 11] 
